Nutrien Reports Third Quarter 2024 Results

• Nine-month results supported by record Potash sales volumes, lower Potash operating costs and higher Retail product margins in North America.
• Commenced share repurchases late in the third quarter and have continued activity in the fourth quarter.

All amounts are in US dollars, except as otherwise noted

Nutrien Ltd. (TSX and NYSE: NTR) announced today its third quarter 2024 results, with net earnings of $25 million ($0.04 diluted net earnings per share). Third quarter 2024 adjusted EBITDA¹ was $1.0 billion and adjusted net earnings per share¹ was $0.39.

"Nutrien delivered higher Potash sales volumes and lower operating costs through the first nine months of 2024, utilizing the strengths of our six-mine network and global distribution capabilities to respond to increased customer demand. We are seeing strong crop nutrient demand in North America for the fall application season following a period of lower field activity in the third quarter," commented Ken Seitz, Nutrien's President and CEO.

"We remain focused on strategic priorities that strengthen the advantages of our business across the ag value chain. This includes accelerating the timeline for achieving our annual consolidated cost savings target, further optimizing capital expenditures, delivering upstream fertilizer sales volume growth and advancing high-return downstream Retail growth opportunities. These initiatives provide a pathway for delivering structural improvements to our earnings and free cash flow through the cycle," added Mr. Seitz.

Highlights²:

• Generated net earnings of $582 million and adjusted EBITDA of $4.3 billion in the first nine months of 2024.

• Retail adjusted EBITDA increased to $1.4 billion in the first nine months of 2024 supported by higher product margins in North America. Lowered full-year 2024 Retail adjusted EBITDA guidance to $1.5 to $1.6 billion as favorable growing conditions in North America resulted in reduced pest pressure and lower field activity in the third quarter.

• Potash adjusted EBITDA decreased to $1.6 billion in the first nine months of 2024 due to lower net selling prices, partially offset by record sales volumes of 11.1 million tonnes. Raised full-year 2024 Potash sales volumes guidance to 13.5 to 13.9 million tonnes due to the continued strength of global demand.

• Nitrogen adjusted EBITDA decreased to $1.4 billion in the first nine months of 2024 as lower net selling prices more than offset lower natural gas costs and higher sales volumes. Total ammonia production increased in the first nine months of 2024, driven by improved natural gas utilization and reliability at our operations in Trinidad.

• Accelerated operational efficiency and cost savings initiatives and expect to achieve approximately $200 million of annual consolidated savings by 2025, ahead of our initial target of 2026.

• Maintained total capital expenditures guidance of $2.2 to $2.3 billion for 2024 and expect capital expenditures in a range of $2.0 to $2.1 billion in 2025 to sustain our assets and deliver on our growth initiatives.

• Repurchased 1.5 million shares for a total of approximately $75 million in the second half of 2024 as of November 5, 2024.
  

1. This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.
2. Our discussion of highlights set out on this page is a comparison of the results for the three and nine months ended September 30, 2024 to the results for the three and nine months ended September 30, 2023, unless otherwise noted.
   
   

Management's Discussion and Analysis

The following management's discussion and analysis ("MD&A") is the responsibility of management and is dated as of November 6, 2024. The Board of Directors ("Board") of Nutrien carries out its responsibility for review of this disclosure principally through its Audit Committee, composed entirely of independent directors. The Audit Committee reviews and, prior to its publication, approves this disclosure pursuant to the authority delegated to it by the Board. The term "Nutrien" refers to Nutrien Ltd. and the terms "we", "us", "our", "Nutrien" and "the Company" refer to Nutrien and, as applicable, Nutrien and its direct and indirect subsidiaries on a consolidated basis. Additional information relating to Nutrien (which, except as otherwise noted, is not incorporated by reference herein), including our annual report dated February 22, 2024 ("2023 Annual Report"), which includes our annual audited consolidated financial statements ("annual financial statements") and MD&A, and our annual information form dated February 22, 2024, each for the year ended December 31, 2023, can be found on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. No update is provided to the disclosure in our 2023 annual MD&A except for material information since the date of our annual MD&A. The Company is a foreign private issuer under the rules and regulations of the US Securities and Exchange Commission (the "SEC").

This MD&A is based on, and should be read in conjunction with, the Company's unaudited interim condensed consolidated financial statements as at and for the three and nine months ended September 30, 2024 ("interim financial statements") based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and prepared in accordance with International Accounting Standard ("IAS") 34 "Interim Financial Reporting", unless otherwise noted. This MD&A contains certain non-GAAP financial measures and ratios and forward-looking statements, which are described in the "Non-GAAP Financial Measures" and the "Forward-Looking Statements" sections, respectively.

Market Outlook and Guidance

Agriculture and Retail Markets

• Favorable growing conditions in the US have supported expectations for record US corn and soybean yields and significant soil nutrient removal in 2024. Prospective crop margins have declined compared to the historically high levels in recent years, however we believe most growers in the US Midwest remain in a healthy financial position. Global grain stocks remain below historical average levels, supporting export demand for North American crops and firm prices for key agriculture commodities such as rice, sugar and palm oil.

• Fertilizer demand in North America for the fall application season has been supported by a relatively early harvest and the need to replenish soil nutrients, following a period of lower field activity in the third quarter.

• Soybean planting in Brazil was delayed by dryness; however, the pace of planting picked up in the second half of October and soybean crop area is expected to increase by one to three percent. Brazilian fertilizer demand is projected to be approximately 46 million tonnes in 2024, in line with historical record levels.

• Australian growing conditions for winter crops have been favorable with timely rains received in key areas, supporting crop production prospects and expected grower returns.

Crop Nutrient Markets

• We raised our 2024 global potash shipment forecast to 70 to 72 million tonnes primarily driven by stronger expected demand in Brazil and Southeast Asia. We believe the increase in global shipments in 2024 has been driven by an underlying increase in consumption in key markets.

• We forecast global potash shipments between 71 and 74 million tonnes in 2025 supported by the need to replenish soil nutrient levels and the relative affordability of potash. We anticipate limited new capacity in 2025 and the potential for incremental supply tightness with demand growth.

• Global ammonia prices have been supported by supply outages, project delays and higher European natural gas values. Chinese urea export restrictions, production challenges from major exporters and strong demand from India and Brazil have tightened the global urea market. US nitrogen inventory was estimated to be well below average levels at the end of the third quarter, which we expect will support demand in the fourth quarter of 2024 and early 2025.

• Global phosphate markets remain tight supported by Chinese export restrictions and production outages in the US. We anticipate some impact on global demand due to tight supply and weaker affordability relative to potash and nitrogen.

Financial and Operational Guidance

• Retail adjusted EBITDA guidance was lowered to $1.5 to $1.6 billion as favorable growing conditions in North America resulted in reduced pest pressure and lower field activity in the third quarter.

• Potash sales volume guidance was raised to 13.5 to 13.9 million tonnes due to the continued strength of global demand. The range reflects our scheduled maintenance downtime in the fourth quarter and the assumption of a relatively short duration labor disruption at the Port of Vancouver.

• Nitrogen sales volume guidance was lowered to 10.6 to 10.8 million tonnes due to extended turnarounds and unplanned outages in the third quarter, including the impact of weather-related events.

• Phosphate sales volume guidance was lowered to 2.4 to 2.5 million tonnes due to weather-related production impacts in the second half of 2024.

• Effective tax rate on adjusted net earnings guidance was lowered primarily due to a change in our expected geographic mix of earnings.

All guidance numbers, including those noted above, are outlined in the table below. Refer to page 65 of Nutrien's 2023 Annual Report for related assumptions and sensitivities.

	2024 Guidance Ranges 1 as of
	November 6, 2024						August 7, 2024
(billions of US dollars, except as otherwise noted)	Low			High			Low		High
Retail adjusted EBITDA	1.5			1.6			1.5		1.7
Potash sales volumes (million tonnes) 2	13.5			13.9			13.2		13.8
Nitrogen sales volumes (million tonnes) 2	10.6			10.8			10.7		11.1
Phosphate sales volumes (million tonnes) 2	2.4			2.5			2.5		2.6
Depreciation and amortization	2.30			2.35			2.2		2.3
Finance costs	0.70			0.75			0.7		0.8
Effective tax rate on adjusted net earnings (%) 3	21.5			22.5			23.0		25.0
Capital expenditures 4	2.2			2.3			2.2		2.3
1 See the "Forward-Looking Statements" section.
2 Manufactured product only.
3 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.
4 Comprised of sustaining capital expenditures, investing capital expenditures and mine development and pre-stripping capital expenditures, which are supplementary financial measures. See the "Other Financial Measures" section.

Consolidated Results

	Three Months Ended September 30							Nine Months Ended September 30
(millions of US dollars, except as otherwise noted)	2024			2023		% Change		2024			2023		% Change
Sales	5,348			5,631		(5)		20,893			23,392		(11)
Gross margin	1,500			1,627		(8)		5,949			6,706		(11)
Expenses	1,304			1,242		5		4,490			4,254		6
Net earnings	25			82		(70)		582			1,106		(47)
Adjusted EBITDA 1	1,010			1,084		(7)		4,300			4,983		(14)
Diluted net earnings per share	0.04			0.15		(73)		1.13			2.18		(48)
Adjusted net earnings per share 1	0.39			0.35		11		3.18			4.01		(21)
1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

Net earnings and adjusted EBITDA decreased in the third quarter of 2024 compared to the same period in 2023, primarily due to lower Potash net selling prices and Retail earnings, partially offset by higher Nitrogen net selling prices and record Potash sales volumes. Net earnings were impacted over the same period due to higher expense for asset retirement obligations at non-operating sites. For the first nine months of the year, net earnings and adjusted EBITDA decreased due to lower fertilizer net selling prices, partially offset by increased Retail earnings, higher Potash sales volumes and lower natural gas costs. Net earnings were also impacted over the same period due to a loss on foreign currency derivatives.

Segment Results

Our discussion of segment results set out on the following pages is a comparison of the results for the three and nine months ended September 30, 2024 to the results for the three and nine months ended September 30, 2023, unless otherwise noted.

Nutrien Ag Solutions ("Retail")

	Three Months Ended September 30							Nine Months Ended September 30
(millions of US dollars, except as otherwise noted)	2024			2023		% Change		2024			2023		% Change
Sales	3,271			3,490		(6)		14,653			16,040		(9)
Cost of goods sold	2,412			2,595		(7)		11,018			12,599		(13)
Gross margin	859			895		(4)		3,635			3,441		6
Adjusted EBITDA 1	151			197		(23)		1,356			1,230		10
1 See Note 2 to the interim financial statements.

• Retail adjusted EBITDA decreased in the third quarter of 2024 due primarily to lower crop nutrient sales volumes in North America and lower seed margins in Brazil. Adjusted EBITDA for the first nine months increased, supported by higher product margins in North America.

	Three Months Ended September 30										Nine Months Ended September 30
	Sales					Gross Margin					Sales					Gross Margin
(millions of US dollars)	2024			2023		2024			2023		2024			2023		2024			2023
Crop nutrients	1,093			1,250		210			262		5,683			6,571		1,150			1,032
Crop protection products	1,518			1,566		360			339		5,365			5,790		1,271			1,220
Seed	132			158		24			54		2,051			2,093		379			391
Services and other	242			235		164			150		690			691		528			522
Merchandise	222			231		37			40		667			750		110			131
Nutrien Financial	85			73		85			73		284			252		284			252
Nutrien Financial elimination 1	(21)			(23)		(21)			(23)		(87)			(107)		(87)			(107)
Total	3,271			3,490		859			895		14,653			16,040		3,635			3,441
1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

• Crop nutrients sales decreased in the third quarter and first nine months of 2024 due to lower sales volumes and selling prices. Gross margin decreased in the third quarter due to reduced field activity in North America that contributed to lower sales volumes and lower international per-tonne margins compared to the historically high levels in the same period last year that were supported by foreign exchange benefits in Argentina. For the first nine months, gross margin increased due to higher per-tonne margins, including growth in our proprietary crop nutritional and biostimulant product lines.

• Crop protection products sales were lower in the third quarter and first nine months of 2024 primarily due to lower selling prices and favorable growing conditions that resulted in reduced pest pressure and lower field activity. Gross margin for the third quarter and first nine months of 2024 were supported by the timing of supplier programs and the selling through of lower cost inventory compared to the same periods in 2023.

• Seed sales and gross margin decreased in the third quarter and first nine months of 2024 mainly due to the impact of dry weather and delayed planting on our proprietary seed business in Brazil.

• Nutrien Financial sales and gross margin increased in the third quarter and first nine months of 2024 due to higher financing rates offered.

Supplemental Data	Three Months Ended September 30										Nine Months Ended September 30
	Gross Margin					% of Product Line 1					Gross Margin					% of Product Line 1
(millions of US dollars, except as otherwise noted)	2024			2023		2024			2023		2024			2023		2024			2023
Proprietary products
Crop nutrients	71			79		38			31		361			347		31			34
Crop protection products	119			107		32			31		429			434		34			36
Seed	4			28		22			54		148			171		39			44
Merchandise	4			2		11			6		11			8		10			7
Total	198			216		24			24		949			960		26			28
1 Represents percentage of proprietary product margins over total product line gross margin.

	Three Months Ended September 30										Nine Months Ended September 30
	Sales Volumes (tonnes - thousands)					Gross Margin / Tonne (US dollars)					Sales Volumes (tonnes - thousands)					Gross Margin / Tonne (US dollars)
	2024			2023		2024			2023		2024			2023		2024			2023
Crop nutrients
North America	931			1,118		165			165		6,693			6,912		147			130
International	956			880		59			88		2,999			2,857		56			47
Total	1,887			1,998		111			131		9,692			9,769		119			106

(percentages)	September 30, 2024			December 31, 2023
Financial performance measures 1, 2
Cash operating coverage ratio	66			68
Adjusted average working capital to sales	20			19
Adjusted average working capital to sales excluding Nutrien Financial	-			1
Nutrien Financial adjusted net interest margin	5.3			5.2
1 Rolling four quarters.
2 These are non-GAAP financial measures. See the "Non-GAAP Financial Measures" section.

Potash

	Three Months Ended September 30							Nine Months Ended September 30
(millions of US dollars, except as otherwise noted)	2024			2023		% Change		2024			2023		% Change
Net sales	884			972		(9)		2,453			2,983		(18)
Cost of goods sold	422			389		8		1,139			1,047		9
Gross margin	462			583		(21)		1,314			1,936		(32)
Adjusted EBITDA 1	555			611		(9)		1,557			1,941		(20)
1 See Note 2 to the interim financial statements.

• Potash adjusted EBITDA decreased in the third quarter and first nine months of 2024 due to lower net selling prices, partially offset by record sales volumes. Higher potash production and the continued advancement of mine automation contributed to our lower controllable cash cost of product manufactured in the first nine months of 2024.

Manufactured Product	Three Months Ended September 30					Nine Months Ended September 30
($ / tonne, except as otherwise noted)	2024			2023		2024			2023
Sales volumes (tonnes - thousands)
North America	1,733			1,674		3,954			3,754
Offshore	2,419			2,221		7,174			6,159
Total sales volumes	4,152			3,895		11,128			9,913
Net selling price
North America	264			298		287			349
Offshore	177			213		183			271
Average net selling price	213			250		220			301
Cost of goods sold	102			100		102			106
Gross margin	111			150		118			195
Depreciation and amortization	43			34		43			35
Gross margin excluding depreciation and amortization 1	154			184		161			230
1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

• Sales volumes for the third quarter and first nine months of 2024 were the highest on record, supported by low channel inventories and strong potash affordability in North America and key offshore markets.

• Net selling price per tonne decreased in the third quarter and first nine months of 2024 due to a decline in benchmark prices compared to the same periods in 2023.

• Cost of goods sold per tonne increased in the third quarter of 2024 as higher depreciation more than offset lower royalties and the favorable impact of higher production volumes. For the first nine months of the year, cost of goods sold per tonne decreased mainly due to higher production volumes and lower royalties.

Supplemental Data	Three Months Ended September 30					Nine Months Ended September 30
	2024			2023		2024			2023
Production volumes (tonnes - thousands)	3,696			3,287		10,836			9,612
Potash controllable cash cost of product manufactured per tonne 1	52			56		52			59
Canpotex sales by market (percentage of sales volumes)
Latin America	46			49		41			47
Other Asian markets 2	27			28		29			28
China	9			10		12			9
India	4			3		5			5
Other markets	14			10		13			11
Total	100			100		100			100
1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.
2 All Asian markets except China and India.

Nitrogen

	Three Months Ended September 30							Nine Months Ended September 30
(millions of US dollars, except as otherwise noted)	2024			2023		% Change		2024			2023		% Change
Net sales	793			723		10		2,732			3,251		(16)
Cost of goods sold	581			569		2		1,835			2,157		(15)
Gross margin	212			154		38		897			1,094		(18)
Adjusted EBITDA 1	355			294		21		1,413			1,539		(8)
1 See Note 2 to the interim financial statements.

• Nitrogen adjusted EBITDA increased in the third quarter of 2024 primarily due to higher net selling prices. Adjusted EBITDA for the first nine months decreased as lower net selling prices more than offset lower natural gas costs and higher sales volumes. Our total ammonia production was flat for the third quarter and increased in the first nine months of the year supported by improved natural gas utilization and reliability at our operations in Trinidad.

Manufactured Product	Three Months Ended September 30					Nine Months Ended September 30
($ / tonne, except as otherwise noted)	2024			2023		2024			2023
Sales volumes (tonnes - thousands)
Ammonia	567			570		1,782			1,785
Urea and ESN®	661			687		2,300			2,386
Solutions, nitrates and sulfates	1,227			1,130		3,698			3,518
Total sales volumes	2,455			2,387		7,780			7,689
Net selling price
Ammonia	375			272		395			489
Urea and ESN®	400			396		427			496
Solutions, nitrates and sulfates	207			205		224			255
Average net selling price	298			276		323			384
Cost of goods sold	215			208		210			239
Gross margin	83			68		113			145
Depreciation and amortization	54			54		54			55
Gross margin excluding depreciation and amortization 1	137			122		167			200
1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

• Sales volumes were higher in the third quarter and first nine months of 2024 primarily due to higher production and strong demand for solutions, nitrates, and sulfates.

• Net selling price per tonne was higher in the third quarter of 2024 primarily due to stronger ammonia benchmark prices. For the first nine months of the year, net selling price per tonne was lower for all major nitrogen products due to weaker benchmark prices in key nitrogen producing regions in the first half of the year.

• Cost of goods sold per tonne increased in the third quarter of 2024 mainly due to higher natural gas costs in Trinidad, partially offset by lower natural gas costs in North America. For the first nine months of the year, cost of goods sold per tonne decreased primarily due to lower natural gas costs across all operating regions.

Supplemental Data	Three Months Ended September 30					Nine Months Ended September 30
	2024			2023		2024			2023
Sales volumes (tonnes - thousands)
Fertilizer	1,319			1,305		4,458			4,419
Industrial and feed	1,136			1,082		3,322			3,270
Production volumes (tonnes - thousands)
Ammonia production - total 1	1,322			1,315		4,157			3,995
Ammonia production - adjusted 1, 2	895			912		2,912			2,880
Ammonia operating rate (%) 2	79			82		87			88
Natural gas costs (US dollars per MMBtu)
Overall natural gas cost excluding realized derivative impact	3.13			2.96		2.98			3.56
Realized derivative impact 3	0.15			(0.01)		0.09			(0.01)
Overall natural gas cost	3.28			2.95		3.07			3.55
1 All figures are provided on a gross production basis in thousands of product tonnes.
2 Excludes Trinidad and Joffre.
3 Includes realized derivative impacts recorded as part of cost of goods sold or other income and expenses. Refer to Note 4 to the interim financial statements.

Phosphate

	Three Months Ended September 30							Nine Months Ended September 30
(millions of US dollars, except as otherwise noted)	2024			2023		% Change		2024			2023		% Change
Net sales	412			444		(7)		1,243			1,460		(15)
Cost of goods sold	383			417		(8)		1,116			1,297		(14)
Gross margin	29			27		7		127			163		(22)
Adjusted EBITDA 1	89			90		(1)		298			340		(12)
1 See Note 2 to the interim financial statements.

• Phosphate adjusted EBITDA was flat in the third quarter of 2024 as higher net selling prices were offset by lower sales volumes and higher input costs. Adjusted EBITDA for the first nine months decreased as lower net selling prices more than offset higher sales volumes and lower costs.

Manufactured Product	Three Months Ended September 30					Nine Months Ended September 30
($ / tonne, except as otherwise noted)	2024			2023		2024			2023
Sales volumes (tonnes - thousands)
Fertilizer	454			519		1,316			1,333
Industrial and feed	168			145		510			465
Total sales volumes	622			664		1,826			1,798
Net selling price
Fertilizer	605			472		611			572
Industrial and feed	797			946		826			1,064
Average net selling price	657			575		671			700
Cost of goods sold	601			528		594			604
Gross margin	56			47		77			96
Depreciation and amortization	121			113		117			118
Gross margin excluding depreciation and amortization 1	177			160		194			214
1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section.

• Sales volumes were lower in the third quarter of 2024 as weather-related events impacted production volumes. Sales volumes for the first nine months were higher than the same period in 2023 due to stronger industrial and feed demand.

• Net selling price per tonne increased in the third quarter of 2024 primarily due to the strength of fertilizer benchmark prices. For the first nine months of 2024, net selling price per tonne decreased due to lower industrial and feed net selling prices which reflect the typical lag in price realizations relative to benchmark prices.

• Cost of goods sold per tonne increased in the third quarter of 2024 primarily due to higher water treatment costs related to weather-related events, higher ammonia input costs and lower production volumes. Cost of goods sold per tonne for the first nine months was lower mainly due to lower ammonia and sulfur input costs.

Supplemental Data	Three Months Ended September 30					Nine Months Ended September 30
	2024			2023		2024			2023
Production volumes (P2O5 tonnes - thousands)	330			354		1,008			1,026
P2O5 operating rate (%)	77			83		79			81

Corporate and Others and Eliminations

	Three Months Ended September 30							Nine Months Ended September 30
(millions of US dollars, except as otherwise noted)	2024			2023		% Change		2024			2023		% Change
Corporate and Others
Selling expenses (recovery)	(2)			(3)		(33)		(7)			(7)		?
General and administrative expenses	90			88		2		277			260		7
Share-based compensation expense (recovery)	1			42		(98)		17			(7)		n/m
Foreign exchange loss, net of related derivatives	31			87		(64)		359			105		242
Other expenses	194			30		547		274			82		234
Adjusted EBITDA 1	(74)			(77)		(4)		(296)			(150)		97
Eliminations
Gross margin	(62)			(32)		94		(24)			72		n/m
Adjusted EBITDA 1	(66)			(31)		113		(28)			83		n/m
1 See Note 2 to the interim financial statements.

• Share-based compensation expense decreased in the third quarter of 2024 due to a lower increase in the fair value of our share-based awards compared to the same period in 2023. We had an expense in the first nine months of 2024 due to an increase in the fair value of our share-based awards compared to a recovery in the same period in 2023 due to a decrease in the fair value of our share-based awards. The fair value of our share-based awards takes into consideration several factors such as our share price movement, our performance relative to our peer group and our return on invested capital.

• Foreign exchange loss, net of related derivatives was lower in the third quarter of 2024 compared to the same period in 2023 due to lower foreign exchange losses in South America. The loss was higher in the first nine months of 2024 compared to the same period in 2023 as it included a previously reported $220 million loss on foreign currency derivatives in Brazil. For further detail regarding the impact of the loss and our remediation efforts, see the Controls and Procedures section of this MD&A and Note 6 to the interim financial statements.

• Other expenses were higher in the third quarter and in the first nine months of 2024 compared to the same periods in 2023 mainly due to a $185 million increase in expense for asset retirement obligations and accrued environmental costs recorded in the third quarter of 2024 related to changes in closure cost estimates at certain non-operating sites. The first nine months of 2023 included a $92 million loss on Blue Chip Swaps. Refer to Note 4 for additional information. This was partially offset by an $80 million gain in the first nine months of 2023 from our other post-retirement benefit plan amendments.

• Eliminations of gross margin between operating segments increased in the third quarter of 2024 mainly due to higher sales volumes at higher average margins compared to the same period in 2023. Eliminations of gross margin between operating segments in the first nine months of 2024 was an elimination due to higher sales volumes at lower average margins compared to a recovery in the same period in 2023.

Finance Costs, Income Taxes and Other Comprehensive Income (Loss)

	Three Months Ended September 30							Nine Months Ended September 30
(millions of US dollars, except as otherwise noted)	2024			2023		% Change		2024			2023		% Change
Finance costs	184			206		(11)		525			580		(9)
Income tax (recovery) expense	(13)			97		n/m		352			766		(54)
Actual effective tax rate including discrete items (%)	(112)			54		n/m		38			41		(7)
Other comprehensive income (loss)	122			(86)		n/m		64			(16)		n/m

• Finance costs were lower in the third quarter and first nine months of 2024 primarily due to lower short-term debt average balances partially offset by higher interest rates on long-term debt.

• Income tax was a recovery in the third quarter of 2024 compared to an expense in the same period in 2023 mainly due to a tax recovery in higher tax jurisdictions, which more than offset tax expense in lower tax jurisdictions. The tax recovery resulted in a negative effective tax rate in the third quarter of 2024 compared to the same period in 2023.
  
  The lower income tax expense in the first nine months of 2024 compared to the same period in 2023 was due to lower earnings and lower discrete tax adjustments. The discrete tax adjustments in 2023 were related to a change in recognition of deferred tax assets in South America as they no longer met the asset recognition criteria and Canadian audit assessments. These factors resulted in a lower effective tax rate in the first nine months of 2024 compared to the same period in 2023.

• Other comprehensive income in the third quarter and first nine months of 2024 compared to a loss for the same periods in 2023 was mainly due to the appreciation of the Australian currency in the third quarter of 2024, and mainly due to appreciation of Australian and Argentinian currencies partially offset by the depreciation of the Brazilian currency in the first nine months of 2024, relative to the US dollar.
  
  

Liquidity and Capital Resources

Sources and Uses of Liquidity

We continued to manage our capital in accordance with our capital allocation strategy. We believe that our internally generated cash flow, supplemented by available borrowings under new or existing financing sources, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements for the foreseeable future. Refer to the "Capital Structure and Management" section for details on our existing long-term debt and credit facilities.

Sources and Uses of Cash

	Three Months Ended September 30							Nine Months Ended September 30
(millions of US dollars, except as otherwise noted)	2024			2023		% Change		2024			2023		% Change
Cash (used in) provided by operating activities	(908)			(469)		94		412			916		(55)
Cash used in investing activities	(506)			(673)		(25)		(1,614)			(2,225)		(27)
Cash provided by financing activities	922			976		(6)		786			981		(20)
Cash used for dividends and share repurchases 1	(318)			(261)		22		(845)			(1,817)		(53)
1 This is a supplementary financial measure. See the "Other Financial Measures" section.

Cash (used in) provided by operating activities	Cash (used in) provided by operating activities in the third quarter and first nine months of 2024 was lower compared to the same periods in 2023 primarily due to lower sales across all segments. This was partially offset by lower cash paid for income taxes and cash paid to our suppliers primarily due to lower cost to purchase inventory for resale and other costs such as royalties and sulfur costs.
Cash used in investing activities	Cash used in investing activities was lower in the third quarter and first nine months of 2024 compared to the same periods in 2023 due to lower capital expenditures and fewer business acquisitions.
Cash provided by financing activities	Cash provided by financing activities in the third quarter and first nine months of 2024 was lower compared to the same periods in 2023 due to lower proceeds from debt. For the first nine months of 2024, we had lower share repurchases compared to the same period in 2023.
Cash used for dividends and share repurchases	Cash used for dividends and share repurchases was higher in the third quarter of 2024 as we repurchased shares in the third quarter of 2024 with no similar share repurchases in the same period in 2023. Cash used for dividends and share repurchases was lower in the first nine months of 2024 from lower share repurchases compared to the same period in 2023.

Financial Condition Review

The following is a comparison of balance sheet categories that are considered material:

	As at
(millions of US dollars, except as otherwise noted)	September 30, 2024			December 31, 2023		$ Change		% Change
Assets
Cash and cash equivalents	520			941		(421)		(45)
Receivables	7,786			5,398		2,388		44
Inventories	4,890			6,336		(1,446)		(23)
Prepaid expenses and other current assets	678			1,495		(817)		(55)
Property, plant and equipment	22,329			22,461		(132)		(1)
Intangible assets	1,877			2,217		(340)		(15)
Liabilities and Shareholders' Equity
Short-term debt	2,967			1,815		1,152		63
Current portion of long-term debt	1,013			512		501		98
Payables and accrued charges	6,613			9,467		(2,854)		(30)
Long-term debt	9,383			8,913		470		5
Retained earnings	11,291			11,531		(240)		(2)

• Explanations for changes in Cash and cash equivalents are in the "Liquidity and Capital Resources - Sources and Uses of Cash" section.

• Receivables increased primarily due to the seasonality of Retail sales, resulting in higher receivables with customers and vendor rebates.

• Inventories decreased due to Retail's seasonal sales and lower-value inventories on hand as related benchmark prices decreased. Generally, we build up our inventory levels in North America near year-end in preparation for the next year's upcoming planting and application seasons.

• Prepaid expenses and other current assets decreased due to the seasonal drawdown of prepaid inventories where Retail typically prepays for products during the fourth quarter and takes possession of inventory throughout the following year.

• Property, plant and equipment decreased due to the impairments related to our Retail - Brazil assets and Geismar Clean Ammonia project in the second quarter of 2024.

• Intangible assets decreased due to an impairment of our Retail - Brazil assets in the second quarter of 2024.

• Short-term debt increased due to drawdowns on our commercial paper program based on our working capital requirements driven by the seasonality of our business.

• Payables and accrued charges decreased primarily due to seasonality of our Retail segment. We generally receive higher customer prepayments in North America near year-end and customers draw down on the balance throughout the year. We also had lower trade and other payables as we settled our obligations with suppliers compared to the buildup of trade and other payables near year-end as we purchase inventory for the upcoming spring and planting seasons.

• Long-term debt including current portion increased due to the issuance of $1,000 million of notes in the first nine months of 2024.

• Retained earnings decreased as dividends declared and share repurchases exceeded net earnings in the first nine months of 2024.
  
  

Capital Structure and Management

Principal Debt Instruments

As part of the normal course of business, we closely monitor our liquidity position. We use a combination of cash generated from operations and short-term and long-term debt to finance our operations. We continually evaluate various financing arrangements and may seek to engage in transactions from time to time when market and other conditions are favorable. We were in compliance with our debt covenants and did not have any changes to our credit ratings for the nine months ended September 30, 2024.

Capital Structure (Debt and Equity)

(millions of US dollars)	September 30, 2024			December 31, 2023
Short-term debt	2,967			1,815
Current portion of long-term debt	1,013			512
Current portion of lease liabilities	364			327
Long-term debt	9,383			8,913
Lease liabilities	1,029			999
Shareholders' equity	25,006			25,201

Commercial Paper, Credit Facilities and Other Debt

We have a total facility limit of approximately $8,200 million comprised of several credit facilities available in the jurisdictions where we operate. Our total facility limit decreased in the third quarter of 2024 due to a reduction in our unsecured revolving term facility limit from $1,500 million to $750 million. In North America, we have a commercial paper program, which is limited to the undrawn amount under our $4,500 million unsecured revolving term credit facility and excess cash invested in highly liquid securities.

As at September 30, 2024, we have utilized $2,895 million of our total facility limit, which includes $2,383 million of commercial paper outstanding. In the third quarter of 2024, we extended the maturities on our $4,500 million unsecured revolving term credit facility to September 4, 2029 and our $750 million unsecured revolving term credit facility to September 3, 2025.

As at September 30, 2024, $231 million in letters of credit were outstanding and committed, with $80 million of remaining credit available under our letter of credit facilities.

Our long-term debt consists primarily of notes and debentures. See the "Capital Structure and Management" section of our 2023 Annual Report for information on balances, rates and maturities for our notes and debentures. On June 21, 2024, we issued $400 million of 5.2 percent senior notes due June 21, 2027 and $600 million of 5.4 percent senior notes due June 21, 2034.

In March 2024, we filed a base shelf prospectus in Canada and the US qualifying the issuance of common shares, debt securities, and other securities during a period of 25 months from March 22, 2024.

See Notes 7, 8 and 9 to the interim financial statements for additional information.

Outstanding Share Data

	As at November 5, 2024
Common shares	493,432,198
Options to purchase common shares	3,111,221

For more information on our capital structure and management, see Note 24 to the annual financial statements in our 2023 Annual Report.

Quarterly Results

(millions of US dollars, except as otherwise noted)	Q3 2024		Q2 2024		Q1 2024		Q4 2023		Q3 2023		Q2 2023		Q1 2023		Q4 2022
Sales	5,348			10,156		5,389		5,664		5,631		11,654		6,107		7,533
Net earnings	25			392		165		176		82		448		576		1,118
Net earnings attributable to equity holders of Nutrien	18			385		158		172		75		440		571		1,112
Net earnings per share attributable to equity holders of Nutrien
Basic	0.04			0.78		0.32		0.35		0.15		0.89		1.14		2.15
Diluted	0.04			0.78		0.32		0.35		0.15		0.89		1.14		2.15

Our quarterly earnings are significantly affected by the seasonality of our business, fertilizer benchmark prices, which have been volatile over the last two years and are affected by demand-supply conditions, grower affordability and weather. See Note 10 to the interim financial statements.

The following table describes certain items that impacted our quarterly earnings:

Quarter	Transaction or Event
Q2 2024	$530 million non-cash impairment of assets comprised of a $335 million non-cash impairment of the Retail - Brazil intangible assets and property plant and equipment due to the ongoing market instability and more moderate margin expectations, and a $195 million non-cash impairment of our Geismar Clean Ammonia project property, plant and equipment as we are no longer pursuing the project. We also recorded a foreign exchange loss of $220 million on foreign currency derivatives in Brazil for the second quarter of 2024.
Q2 2023	$698 million non-cash impairment of assets comprised of a $233 million non-cash impairment of our Phosphate White Springs property, plant and equipment due to a decrease in our forecasted phosphate margins and a $465 million non-cash impairment of our Retail - South America assets primarily related to goodwill mainly due to the impact of crop input price volatility, more moderate long-term growth assumptions and higher interest rates, which lowered our forecasted earnings.

Critical Accounting Estimates

Our significant accounting policies are disclosed in our 2023 Annual Report. We have discussed the development, selection and application of our key accounting policies, and the critical accounting estimates and assumptions they involve, with the Audit Committee of the Board. Our critical accounting estimates are discussed on pages 72 to 74 of our 2023 Annual Report. There were no material changes to our critical accounting estimates for the three or nine months ended September 30, 2024.

Controls and Procedures

We are required to maintain disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act") and National Instrument 52-109 - "Certification of Disclosure in Issuers' Annual and Interim Filings" ("NI 52-109") designed to provide reasonable assurance that information required to be disclosed by Nutrien in its annual filings, interim filings (as these terms are defined in NI 52-109), and other reports filed or submitted by us under securities legislation is recorded, processed, summarized and reported within the required time periods. As at September 30, 2024, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective due to the material weakness described below.

Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting ("ICFR"), as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, as amended, and NI 52-109. ICFR is designed to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with IFRS. Any system of ICFR, no matter how well designed, has inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have designed ICFR based on the framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control - Integrated Framework (2013). A material weakness is a deficiency, or a combination of deficiencies, in ICFR, such that there is a reasonable possibility that a material misstatement of the annual financial statements, or interim financial statements, will not be prevented or detected on a timely basis.

As at September 30, 2024, we have a material weakness related to our controls over derivative contract authorization in Brazil, which was identified by our management in late June 2024 and which resulted in unauthorized execution of derivative contracts in the second quarter of 2024. This material weakness did not result in any errors or a material misstatement in our interim or annual financial statements.

In the second quarter of 2024, changes were introduced to our derivative contract authorization and execution process in Brazil. As a result of these changes, our controls were not designed effectively to ensure that segregation of duties was maintained, and checks of authorization were performed in a timely manner and that derivative contracts entered into were recorded in our treasury reporting systems on a timely basis.

Notwithstanding this identified material weakness, we believe that our interim financial statements present fairly, in all material respects, our business, financial condition and results of operations for the periods presented.

Remediation Plan

The control deficiency described above was identified by our management in late June 2024, prior to the preparation and filing of our interim financial statements as at June 30, 2024 and for the three and six months then ended. We have prioritized the remediation of the material weakness described above and are working to complete certain remediation activities under the oversight of the Audit Committee to resolve the issue.

Specific actions that are being taken to remediate this material weakness include the following:

• redesigning certain processes and controls relating to derivative contract authorization and execution in Brazil, including with respect to segregation of duties, compliance and confirmation, accounting and reconciliation activities, authority limits, and systems controls; and,
• enhancing the supervision and review activities related to trading in derivative contracts in Brazil.

As of September 30, 2024, we have taken steps to implement our remediation plan; however, the material weakness will not be considered remediated until the enhanced controls operate for a sufficient period of time and management has concluded, through testing, that these controls are designed and operating effectively. We will continue to monitor our remediation plan in relation to the material weakness with the intention of such being remediated by the end of 2024.

Other than the remediation steps relating to the material weakness described above, there has been no change in our ICFR during the three months ended September 30, 2024 that has materially affected, or is reasonably likely to materially affect, our ICFR.

Forward-Looking Statements

Certain statements and other information included in this document, including within the "Market Outlook and Guidance" section, constitute "forward-looking information" or "forward-looking statements" (collectively, "forward-looking statements") under applicable securities laws (such statements are often accompanied by words such as "anticipate", "forecast", "expect", "believe", "may", "will", "should", "estimate", "project", "intend" or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to:

Nutrien's business strategies, plans, prospects and opportunities; Nutrien's 2024 full-year guidance, including expectations regarding Retail adjusted EBITDA, Potash sales volumes, Nitrogen sales volumes, Phosphate sales volumes, depreciation and amortization, finance costs, effective tax rate and capital expenditures; expectations regarding certain targets, including our targeted $200 million in annual consolidated cost savings, expected capital expenditures in 2025, delivering upstream fertilizer sales volume growth and advancing high-return downstream Retail growth opportunities, and the anticipated benefits thereof, including with respect to earnings and cash flow; expectations regarding our capital allocation intentions and strategies; our ability to advance strategic initiatives and high value growth investments; capital spending expectations for 2024 and beyond; expectations regarding performance of our operating segments in 2024 and beyond, including increased potash shipment forecasts; expectations regarding a strong fall fertilizer application season in North America; our operating segment market outlooks and our expectations for market conditions and fundamentals, and the anticipated supply and demand for our products and services, expected market, industry and growing conditions with respect to crop nutrient application rates, planted acres, grower crop investment, crop mix, including the need to replenish soil nutrient levels, production volumes and expenses, shipments, natural gas costs and availability, consumption, prices, operating rates and the impact of seasonality, import and export volumes, economic sanctions and restrictions, operating rates, inventories, crop development and natural gas curtailments; the negotiation of sales contracts; acquisitions and divestitures and the anticipated benefits thereof; expectations in connection with our ability to deliver long-term returns to shareholders, and expectations related to the timing and outcome of remediation efforts for the material weakness in ICFR related to derivative contract authorization.

These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty.

The additional key assumptions that have been made in relation to the operation of our business as currently planned and our ability to achieve our business objectives include, among other things, assumptions with respect to: our ability to successfully implement our business strategies, growth and capital allocation investments and initiatives that we will conduct our operations and achieve results of operations as anticipated; our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures, and that we will be able to implement our standards, controls, procedures and policies in respect of any acquired businesses and to realize the expected synergies on the anticipated timeline or at all; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, expenses, margins, demand, supply, product availability, shipments, consumption, weather conditions, including the current El Niño weather pattern, supplier agreements, product distribution agreements, inventory levels, exports, crop development and cost of labor and interest, exchange and effective tax rates; potash demand growth in offshore markets and normalization of Canpotex port operations; global economic conditions and the accuracy of our market outlook expectations for 2024 and in the future; assumptions related to our assessment of recoverable amount estimates of our assets, including in relation to our Retail - Brazil business asset impairments; our intention to complete share repurchases under our normal course issuer bid programs, the funding of such share repurchases, existing and future market conditions, including with respect to the price of our common shares, capital allocation priorities and compliance with respect to applicable limitations under securities laws and regulations and stock exchange policies and assumptions related to our ability to fund our dividends at the current level; our expectations regarding the impacts, direct and indirect, of certain geopolitical conflicts, including the war in Eastern Europe and the conflict in the Middle East on, among other things, global supply and demand, including for crop nutrients, energy and commodity prices, global interest rates, supply chains and the global macroeconomic environment, including inflation; assumptions regarding future markets for clean ammonia; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; our ability to maintain investment grade ratings and achieve our performance targets; our ability to successfully negotiate sales and other contracts and our ability to successfully implement new initiatives and programs; and our ability to successfully remediate the material weakness in our ICFR related to derivative contract authorization.

Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: general global economic, market and business conditions; failure to achieve expected results of our business strategy, capital allocation initiatives, results of operations or targets, such as our targeted $200 million in annual consolidated cost savings, expected capital expenditures in 2025, delivering upstream fertilizer sales volume growth and advancing high-return downstream Retail growth opportunities; failure to complete announced and future acquisitions or divestitures at all or on the expected terms and within the expected timeline; seasonality; climate change and weather conditions, including the current El Niño weather pattern (and transition to La Niña weather pattern), including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including tariffs, trade restrictions and climate change initiatives), government ownership requirements, changes in environmental, tax, antitrust and other laws or regulations and the interpretation thereof; political or military risks, including civil unrest, actions by armed groups or conflict and malicious acts including terrorism and industrial espionage; our ability to access sufficient, cost-effective and timely transportation, distribution and storage of products (including potential rail transportation and port disruptions due to labor strikes and/or work stoppages or other similar actions); the occurrence of a major environmental or safety incident or becoming subject to legal or regulatory proceedings; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities or challenges related to our major facilities that are out of our control; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; the risk that rising interest rates and/or deteriorated business operating results may result in the further impairment of assets or goodwill attributed to certain of our cash generating units; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; geopolitical conflicts, including the war in Eastern Europe and the conflict in the Middle East, and their potential impact on, among other things, global market conditions and supply and demand, including for crop nutrients, energy and commodity prices, interest rates, supply chains and the global economy generally; our ability to execute on our strategies related to environmental, social and governance matters, and achieve related expectations, targets and commitments, including risks associated with disclosure thereof; failure to remediate the material weakness in our ICFR related to derivative contract authorization; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the SEC.

The purpose of our revised Retail adjusted EBITDA and our depreciation and amortization, finance costs, effective tax rate and capital expenditures guidance ranges are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.

Terms and Definitions

For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the "Terms & Definitions" section of our 2023 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, "n/m" indicates information that is not meaningful, and all financial amounts are stated in millions of US dollars, unless otherwise noted.

About Nutrien

Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.

More information about Nutrien can be found at www.nutrien.com.

Selected financial data for download can be found in our data tool at www.nutrien.com/investors/interactive-datatool
Such data is not incorporated by reference herein.

Nutrien will host a Conference Call on Thursday, November 7, 2024 at 10:00 a.m. Eastern Time.

Telephone conference dial-in numbers:

• From Canada and the US 1-888-870-4559
• International 647-931-1822
• No access code required. Please dial in 15 minutes prior to ensure you are placed on the call in a timely manner.

Live Audio Webcast: Visit https://www.nutrien.com/news/events/2024-q3-earnings-conference-call

Non-GAAP Financial Measures

We use both IFRS measures and certain non-GAAP financial measures to assess performance. Non-GAAP financial measures are financial measures disclosed by the Company that: (a) depict historical or expected future financial performance, financial position or cash flow of the Company; (b) with respect to their composition, exclude amounts that are included in, or include amounts that are excluded from, the composition of the most directly comparable financial measure disclosed in the primary financial statements of the Company; (c) are not disclosed in the financial statements of the Company; and (d) are not a ratio, fraction, percentage or similar representation. Non-GAAP ratios are financial measures disclosed by the Company that are in the form of a ratio, fraction, percentage or similar representation that has a non-GAAP financial measure as one or more of its components, and that are not disclosed in the financial statements of the Company.

These non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under IFRS and, therefore, are unlikely to be comparable to similar financial measures presented by other companies. Management believes these non-GAAP financial measures and non-GAAP ratios provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-GAAP financial measures and non-GAAP ratios should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

The following section outlines our non-GAAP financial measures and non-GAAP ratios, their compositions, and why management uses each measure. It also includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-GAAP financial measures and non-GAAP ratios are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As additional non-recurring or unusual items arise in the future, we generally exclude these items in our calculations.

Adjusted EBITDA (Consolidated)

Most directly comparable IFRS financial measure: Net earnings (loss).

Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, share-based compensation and certain foreign exchange gain/loss (net of related derivatives). We also adjust this measure for the following other income and expenses that are excluded when management evaluates the performance of our day-to-day operations: integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on disposal of certain businesses and investments, asset retirement obligations ("ARO") and accrued environmental costs ("ERL") related to our non-operating sites, and loss related to financial instruments in Argentina.

Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations and as a component of employee remuneration calculations.

	Three Months Ended September 30					Nine Months Ended September 30
(millions of US dollars)	2024			2023		2024			2023
Net earnings	25			82		582			1,106
Finance costs	184			206		525			580
Income tax (recovery) expense	(13)			97		352			766
Depreciation and amortization	598			552		1,749			1,604
EBITDA 1	794			937		3,208			4,056
Adjustments:
Share-based compensation expense (recovery)	1			42		17			(7)
Foreign exchange loss, net of related derivatives	31			87		359			105
ARO/ERL related expenses for non-operating sites	184			4		152			10
Loss related to financial instruments in Argentina	?			?		34			92
Integration and restructuring related costs	?			14		?			29
Impairment of assets	?			?		530			698
Adjusted EBITDA	1,010			1,084		4,300			4,983
1 EBITDA is calculated as net earnings before finance costs, income taxes, and depreciation and amortization.

Adjusted Net Earnings and Adjusted Net Earnings Per Share

Most directly comparable IFRS financial measure: Net earnings (loss) and diluted net earnings (loss) per share.

Definition: Adjusted net earnings and related per share information are calculated as net earnings (loss) before share-based compensation and certain foreign exchange gain/loss (net of related derivatives), net of tax. We also adjust this measure for the following other income and expenses (net of tax) that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on disposal of certain businesses and investments, gain or loss on early extinguishment of debt or on settlement of derivatives due to discontinuance of hedge accounting, asset retirement obligations and accrued environmental costs related to our non-operating sites, loss related to financial instruments in Argentina, change in recognition of tax losses and deductible temporary differences related to impairments and certain changes to tax declarations. We generally apply the annual forecasted effective tax rate to specific adjustments during the year, and at year-end, we apply the actual effective tax rate.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations and is used as a component of employee remuneration calculations.

	Three Months Ended September 30, 2024						Nine Months Ended September 30, 2024
(millions of US dollars, except as otherwise noted)	Increases (Decreases)		Post-Tax		Per Diluted Share		Increases (Decreases)		Post-Tax		Per Diluted Share
Net earnings attributable to equity holders of Nutrien			18		0.04				561		1.13
Adjustments:
Share-based compensation expense	1		1		?		17		13		0.03
Foreign exchange loss, net of related derivatives	31		38		0.08		359		361		0.73
Impairment of assets	?		?		?		530		491		1.00
ARO/ERL related expenses for non-operating sites	184		134		0.27		152		112		0.22
Loss related to financial instruments in Argentina	?		?		?		34		34		0.07
Adjusted net earnings			191		0.39				1,572		3.18

	Three Months Ended September 30, 2023						Nine Months Ended September 30, 2023
(millions of US dollars, except as otherwise noted)	Increases (Decreases)		Post-Tax		Per Diluted Share		Increases (Decreases)		Post-Tax		Per Diluted Share
Net earnings attributable to equity holders of Nutrien			75		0.15				1,086		2.18
Adjustments:
Share-based compensation expense (recovery)	42		19		0.04		(7)		(4)		(0.01)
Foreign exchange loss, net of related derivatives	87		71		0.14		105		80		0.16
Integration and restructuring related costs	14		6		0.02		29		17		0.03
Impairment of assets	?		?		?		698		653		1.32
ARO/ERL related expenses for non-operating sites	4		2		?		10		6		0.02
Loss related to financial instruments in Argentina	?		?		?		92		92		0.18
Change in recognition of deferred tax assets	?		?		?		66		66		0.13
Adjusted net earnings			173		0.35				1,996		4.01

Effective Tax Rate on Adjusted Net Earnings Guidance

Effective tax rate on adjusted net earnings guidance is a forward-looking non-GAAP financial measure as it includes adjusted net earnings, which is a non-GAAP financial measure. It is provided to assist readers in understanding our expected financial results. Effective tax rate on adjusted net earnings guidance excludes certain items that management is aware of that permit management to focus on the performance of our operations (see the Adjusted Net Earnings and Adjusted Net Earnings Per Share section for items generally adjusted). We do not provide a reconciliation of this forward-looking measure to the most directly comparable financial measures calculated and presented in accordance with IFRS because a meaningful or accurate calculation of reconciling items and the information is not available without unreasonable effort due to unknown variables, including the timing and amount of certain reconciling items, and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. The probable significance of such unavailable information, which could be material to future results, cannot be addressed.

Gross Margin Excluding Depreciation and Amortization Per Tonne - Manufactured Product

Most directly comparable IFRS financial measure: Gross margin.

Definition: Gross margin per tonne less depreciation and amortization per tonne for manufactured products. Reconciliations are provided in the "Segment Results" section.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

Potash Controllable Cash Cost of Product Manufactured ("COPM") Per Tonne

Most directly comparable IFRS financial measure: Cost of goods sold ("COGS") for the Potash segment.

Definition: Total Potash COGS excluding depreciation and amortization expense included in COPM, royalties, natural gas costs and carbon taxes, change in inventory, and other adjustments, divided by potash production tonnes.

Why we use the measure and why it is useful to investors: To assess operational performance. Potash controllable cash COPM excludes the effects of production from other periods and the impacts of our long-term investment decisions, supporting a focus on the performance of our day-to-day operations. Potash controllable cash COPM also excludes royalties and natural gas costs and carbon taxes, which management does not consider controllable, as they are primarily driven by regulatory and market conditions.

	Three Months Ended September 30					Nine Months Ended September 30
(millions of US dollars, except as otherwise noted)	2024			2023		2024			2023
Total COGS - Potash	422			389		1,139			1,047
Change in inventory	(51)			(73)		(30)			(47)
Other adjustments 1	(5)			(2)		(14)			(19)
COPM	366			314		1,095			981
Depreciation and amortization in COPM	(145)			(102)		(439)			(303)
Royalties in COPM	(23)			(20)		(62)			(77)
Natural gas costs and carbon taxes in COPM	(7)			(9)		(27)			(34)
Controllable cash COPM	191			183		567			567
Production tonnes (tonnes - thousands)	3,696			3,287		10,836			9,612
Potash controllable cash COPM per tonne	52			56		52			59
1 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

Nutrien Financial Adjusted Net Interest Margin

Definition: Nutrien Financial revenue less deemed interest expense divided by average Nutrien Financial net receivables outstanding for the last four rolling quarters.

Why we use the measure and why it is useful to investors: Used by credit rating agencies and others to evaluate the financial performance of Nutrien Financial.

	Rolling four quarters ended September 30, 2024
(millions of US dollars, except as otherwise noted)	Q4 2023		Q1 2024		Q2 2024		Q3 2024		Total/Average
Nutrien Financial revenue	70		66		133		85
Deemed interest expense 1	(36)		(27)		(50)		(52)
Net interest	34		39		83		33		189
Average Nutrien Financial net receivables	2,893		2,489		4,560		4,318		3,565
Nutrien Financial adjusted net interest margin (%)									5.3
	Rolling four quarters ended December 31, 2023
(millions of US dollars, except as otherwise noted)	Q1 2023		Q2 2023		Q3 2023		Q4 2023		Total/Average
Nutrien Financial revenue	57		122		73		70
Deemed interest expense 1	(20)		(39)		(41)		(36)
Net interest	37		83		32		34		186
Average Nutrien Financial net receivables	2,283		4,716		4,353		2,893		3,561
Nutrien Financial adjusted net interest margin (%)									5.2
1 Average borrowing rate applied to the notional debt required to fund the portfolio of receivables from customers monitored and serviced by Nutrien Financial.

Retail Cash Operating Coverage Ratio

Definition: Retail selling, general and administrative, and other expenses (income), excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate free cash flow.

	Rolling four quarters ended September 30, 2024
(millions of US dollars, except as otherwise noted)	Q4 2023		Q1 2024		Q2 2024		Q3 2024		Total
Selling expenses	841		790		1,005		815		3,451
General and administrative expenses	55		52		51		51		209
Other expenses	77		22		41		32		172
Operating expenses	973		864		1,097		898		3,832
Depreciation and amortization in operating expenses	(199)		(190)		(193)		(182)		(764)
Operating expenses excluding depreciation and amortization	774		674		904		716		3,068
Gross margin	989		747		2,029		859		4,624
Depreciation and amortization in cost of goods sold	2		4		3		8		17
Gross margin excluding depreciation and amortization	991		751		2,032		867		4,641
Cash operating coverage ratio (%)									66
	Rolling four quarters ended December 31, 2023
(millions of US dollars, except as otherwise noted)	Q1 2023		Q2 2023		Q3 2023		Q4 2023		Total
Selling expenses	765		971		798		841		3,375
General and administrative expenses	50		55		57		55		217
Other expenses	15		29		37		77		158
Operating expenses	830		1,055		892		973		3,750
Depreciation and amortization in operating expenses	(179)		(185)		(186)		(199)		(749)
Operating expenses excluding depreciation and amortization	651		870		706		774		3,001
Gross margin	615		1,931		895		989		4,430
Depreciation and amortization in cost of goods sold	2		3		3		2		10
Gross margin excluding depreciation and amortization	617		1,934		898		991		4,440
Cash operating coverage ratio (%)									68

Retail Adjusted Average Working Capital to Sales and Retail Adjusted Average Working Capital to Sales Excluding Nutrien Financial

Definition: Retail adjusted average working capital divided by Retail adjusted sales for the last four rolling quarters. We exclude in our calculations the sales and working capital of certain acquisitions during the first year following the acquisition. We also look at this metric excluding Nutrien Financial revenue and working capital.

Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively. The metric excluding Nutrien Financial shows the impact that the working capital of Nutrien Financial has on the ratio.

	Rolling four quarters ended September 30, 2024
(millions of US dollars, except as otherwise noted)	Q4 2023		Q1 2024		Q2 2024		Q3 2024		Average/Total
Current assets	10,498		11,821		11,181		10,559
Current liabilities	(8,210)		(8,401)		(8,002)		(5,263)
Working capital	2,288		3,420		3,179		5,296		3,546
Working capital from certain recent acquisitions	?		?		?		?
Adjusted working capital	2,288		3,420		3,179		5,296		3,546
Nutrien Financial working capital	(2,893)		(2,489)		(4,560)		(4,318)
Adjusted working capital excluding Nutrien Financial	(605)		931		(1,381)		978		(19)
Sales	3,502		3,308		8,074		3,271
Sales from certain recent acquisitions	?		?		?		?
Adjusted sales	3,502		3,308		8,074		3,271		18,155
Nutrien Financial revenue	(70)		(66)		(133)		(85)
Adjusted sales excluding Nutrien Financial	3,432		3,242		7,941		3,186		17,801
Adjusted average working capital to sales (%)									20
Adjusted average working capital to sales excluding Nutrien Financial (%)									-
	Rolling four quarters ended December 31, 2023
(millions of US dollars, except as otherwise noted)	Q1 2023		Q2 2023		Q3 2023		Q4 2023		Average/Total
Current assets	13,000		11,983		10,398		10,498
Current liabilities	(8,980)		(8,246)		(5,228)		(8,210)
Working capital	4,020		3,737		5,170		2,288		3,804
Working capital from certain recent acquisitions	?		?		?		?
Adjusted working capital	4,020		3,737		5,170		2,288		3,804
Nutrien Financial working capital	(2,283)		(4,716)		(4,353)		(2,893)
Adjusted working capital excluding Nutrien Financial	1,737		(979)		817		(605)		243
Sales	3,422		9,128		3,490		3,502
Sales from certain recent acquisitions	?		?		?		?
Adjusted sales	3,422		9,128		3,490		3,502		19,542
Nutrien Financial revenue	(57)		(122)		(73)		(70)
Adjusted sales excluding Nutrien Financial	3,365		9,006		3,417		3,432		19,220
Adjusted average working capital to sales (%)									19
Adjusted average working capital to sales excluding Nutrien Financial (%)									1

Other Financial Measures

Selected Additional Financial Data

Nutrien Financial	As at September 30, 2024									As at December 31, 2023
(millions of US dollars)	Current	<31 Days Past Due	31-90 Days Past Due	>90 Days Past Due	Gross Receivables	Allowance 1		Net Receivables		Net Receivables
North America	3,213	105	79	191	3,588	(61)		3,527		2,206
International	646	62	25	69	802	(11)		791		687
Nutrien Financial receivables	3,859	167	104	260	4,390	(72)		4,318		2,893
1 Bad debt expense on the above receivables for the nine months ended September 30, 2024 and 2023 were $44 million and $36 million, respectively, in the Retail segment.

Supplementary Financial Measures

Supplementary financial measures are financial measures disclosed by the Company that (a) are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company, (b) are not disclosed in the financial statements of the Company, (c) are not non-GAAP financial measures, and (d) are not non-GAAP ratios.

The following section provides an explanation of the composition of those supplementary financial measures, if not previously provided.

Sustaining capital expenditures: Represents capital expenditures that are required to sustain operations at existing levels and include major repairs and maintenance and plant turnarounds.

Investing capital expenditures: Represents capital expenditures related to significant expansions of current operations or to create cost savings (synergies). Investing capital expenditures excludes capital outlays for business acquisitions and equity-accounted investees.

Mine development and pre-stripping capital expenditures: Represents capital expenditures that are required for activities to open new areas underground and/or develop a mine or ore body to allow for future production mining and activities required to prepare and/or access the ore, i.e., removal of an overburden that allows access to the ore.

Cash used for dividends and share repurchases: Calculated as dividends paid to Nutrien's shareholders plus repurchase of common shares as reflected in the unaudited condensed consolidated statements of cash flows. This measure is useful as it represents return of capital to shareholders.

Condensed Consolidated Financial Statements

Unaudited
Condensed Consolidated Statements of Earnings

			Three Months Ended					Nine Months Ended
			September 30					September 30
(millions of US dollars, except as otherwise noted)	Note		2024			2023		2024			2023
SALES	2, 11		5,348			5,631		20,893			23,392
Freight, transportation and distribution			263			263		741			714
Cost of goods sold			3,585			3,741		14,203			15,972
GROSS MARGIN			1,500			1,627		5,949			6,706
Selling expenses			820			799		2,622			2,548
General and administrative expenses			156			151		468			453
Provincial mining taxes			74			96		210			319
Share-based compensation expense (recovery)			1			42		17			(7)
Impairment of assets	3		?			?		530			698
Foreign exchange loss, net of related derivatives	6		31			87		359			105
Other expenses	4		222			67		284			138
EARNINGS BEFORE FINANCE COSTS AND INCOME TAXES			196			385		1,459			2,452
Finance costs			184			206		525			580
EARNINGS BEFORE INCOME TAXES			12			179		934			1,872
Income tax (recovery) expense	5		(13)			97		352			766
NET EARNINGS			25			82		582			1,106
Attributable to
Equity holders of Nutrien			18			75		561			1,086
Non-controlling interest			7			7		21			20
NET EARNINGS			25			82		582			1,106
NET EARNINGS PER SHARE ATTRIBUTABLE TO EQUITY HOLDERS OF NUTRIEN ("EPS")
Basic			0.04			0.15		1.13			2.18
Diluted			0.04			0.15		1.13			2.18
Weighted average shares outstanding for basic EPS			494,743,000			494,517,000		494,653,000			496,999,000
Weighted average shares outstanding for diluted EPS			494,857,000			495,056,000		494,851,000			497,708,000

Condensed Consolidated Statements of Comprehensive Income (Loss)

	Three Months Ended					Nine Months Ended
	September 30					September 30
(millions of US dollars, net of related income taxes)	2024			2023		2024			2023
NET EARNINGS	25			82		582			1,106
Other comprehensive income (loss)
Items that will not be reclassified to net earnings:
Net actuarial loss on defined benefit plans	?			?		?			(3)
Net fair value gain (loss) on investments	35			(6)		53			5
Items that have been or may be subsequently reclassified to net earnings:
Gain (loss) on currency translation of foreign operations	85			(64)		28			(14)
Other	2			(16)		(17)			(4)
OTHER COMPREHENSIVE INCOME (LOSS)	122			(86)		64			(16)
COMPREHENSIVE INCOME (LOSS)	147			(4)		646			1,090
Attributable to
Equity holders of Nutrien	139			(11)		625			1,070
Non-controlling interest	8			7		21			20
COMPREHENSIVE INCOME (LOSS)	147			(4)		646			1,090
(See Notes to the Condensed Consolidated Financial Statements)

Condensed Consolidated Statements of Cash Flows

			Three Months Ended					Nine Months Ended
			September 30					September 30
(millions of US dollars)	Note		2024			2023		2024			2023
						Note 1					Note 1
OPERATING ACTIVITIES
Net earnings			25			82		582			1,106
Adjustments for:
Depreciation and amortization			598			552		1,749			1,604
Share-based compensation expense (recovery)			1			42		17			(7)
Impairment of assets	3		?			?		530			698
(Recovery of) provision for deferred income tax			(36)			55		15			176
Net (undistributed) distributed earnings of equity-accounted investees			(24)			(28)		14			112
Fair value adjustment to derivatives	6		(180)			(27)		6			5
Loss related to financial instruments in Argentina	4		?			?		34			92
Long-term income tax receivables and payables			9			1		17			(89)
Other long-term assets, liabilities and miscellaneous			251			53		321			39
Cash from operations before working capital changes			644			730		3,285			3,736
Changes in non-cash operating working capital:
Receivables			418			627		(2,394)			(1,491)
Inventories and prepaid expenses and other current assets			373			794		2,265			3,366
Payables and accrued charges			(2,343)			(2,620)		(2,744)			(4,695)
CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES			(908)			(469)		412			916
INVESTING ACTIVITIES
Capital expenditures 1			(529)			(634)		(1,449)			(1,890)
Business acquisitions, net of cash acquired			(2)			?		(6)			(116)
(Purchase of) proceeds from investments, held within three months, net			(15)			(36)		(30)			(134)
Purchase of investments			(1)			(12)		(112)			(12)
Net changes in non-cash working capital			30			36		(55)			(68)
Other			11			(27)		38			(5)
CASH USED IN INVESTING ACTIVITIES			(506)			(673)		(1,614)			(2,225)
FINANCING ACTIVITIES
Proceeds from (repayment of) debt, maturing within three months, net			1,378			1,445		1,089			2,213
Proceeds from debt	8		?			?		998			1,500
Repayment of debt			(43)			(118)		(132)			(635)
Repayment of principal portion of lease liabilities			(98)			(91)		(300)			(278)
Dividends paid to Nutrien's shareholders			(268)			(261)		(795)			(770)
Repurchase of common shares	9		(50)			?		(50)			(1,047)
Issuance of common shares			7			1		16			32
Other			(4)			?		(40)			(34)
CASH PROVIDED BY FINANCING ACTIVITIES			922			976		786			981
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS			8			(17)		(5)			(19)
DECREASE IN CASH AND CASH EQUIVALENTS			(484)			(183)		(421)			(347)
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD			1,004			737		941			901
CASH AND CASH EQUIVALENTS - END OF PERIOD			520			554		520			554
Cash and cash equivalents is composed of:
Cash			472			508		472			508
Short-term investments			48			46		48			46
			520			554		520			554
SUPPLEMENTAL CASH FLOWS INFORMATION
Interest paid			148			137		496			462
Income taxes paid			127			133		260			1,722
Total cash outflow for leases			134			125		418			373
1 Includes additions to property, plant and equipment, and intangible assets for the three months ended September 30, 2024 of $489 million and $40 million (2023 - $580 million and $54 million), respectively, and for the nine months ended September 30, 2024 of $1,333 million and $116 million (2023 - $1,734 million and $156 million), respectively.
(See Notes to the Condensed Consolidated Financial Statements)

Condensed Consolidated Statements of Changes in Shareholders' Equity

							Accumulated Other Comprehensive
							(Loss) Income ("AOCI")
(millions of US dollars, inclusive of related tax, except as otherwise noted)	Number of Common Shares		Share Capital		Contributed Surplus		(Loss) Gain on Currency Translation of Foreign Operations		Other		Total AOCI		Retained Earnings		Equity Holders of Nutrien		Non-Controlling Interest		Total Equity
BALANCE - DECEMBER 31, 2022	507,246,105		14,172		109		(374)		(17)		(391)		11,928		25,818		45		25,863
Net earnings	?		?		?		?		?		?		1,086		1,086		20		1,106
Other comprehensive loss	?		?		?		(14)		(2)		(16)		?		(16)		?		(16)
Shares repurchased (Note 9)	(13,378,189)		(374)		(26)		?		?		?		(600)		(1,000)		?		(1,000)
Dividends declared - $1.59/share	?		?		?		?		?		?		(789)		(789)		?		(789)
Non-controlling interest transactions	?		?		?		?		?		?		?		?		(14)		(14)
Effect of share-based compensation including issuance of common shares	664,230		39		(1)		?		?		?		?		38		?		38
Transfer of net gain on sale of investment	?		?		?		?		(14)		(14)		14		?		?		?
Transfer of net loss on cash flow hedges	?		?		?		?		8		8		?		8		?		8
Transfer of net actuarial loss on defined benefit plans	?		?		?		?		3		3		(3)		?		?		?
BALANCE - SEPTEMBER 30, 2023	494,532,146		13,837		82		(388)		(22)		(410)		11,636		25,145		51		25,196
BALANCE - DECEMBER 31, 2023	494,551,730		13,838		83		(286)		(10)		(296)		11,531		25,156		45		25,201
Net earnings	?		?		?		?		?		?		561		561		21		582
Other comprehensive income	?		?		?		28		36		64		?		64		?		64
Shares repurchased (Note 9)	(1,039,185)		(29)		(21)		?		?		?		(1)		(51)		?		(51)
Dividends declared - $1.62/share	?		?		?		?		?		?		(800)		(800)		?		(800)
Non-controlling interest transactions	?		?		?		?		?		?		?		?		(26)		(26)
Effect of share-based compensation including issuance of common shares	369,904		18		5		?		?		?		?		23		?		23
Transfer of net loss on cash flow hedges	?		?		?		?		13		13		?		13		?		13
BALANCE - SEPTEMBER 30, 2024	493,882,449		13,827		67		(258)		39		(219)		11,291		24,966		40		25,006
(See Notes to the Condensed Consolidated Financial Statements)

Condensed Consolidated Balance Sheets

			September 30					December 31
As at (millions of US dollars)	Note		2024			2023		2023
ASSETS
Current assets
Cash and cash equivalents			520			554		941
Receivables	6, 7, 11		7,786			7,713		5,398
Inventories			4,890			5,169		6,336
Prepaid expenses and other current assets			678			656		1,495
			13,874			14,092		14,170
Non-current assets
Property, plant and equipment	3		22,329			22,150		22,461
Goodwill			12,122			12,078		12,114
Intangible assets	3		1,877			2,219		2,217
Investments			739			731		736
Other assets			970			959		1,051
TOTAL ASSETS			51,911			52,229		52,749
LIABILITIES
Current liabilities
Short-term debt	7		2,967			4,354		1,815
Current portion of long-term debt	8		1,013			?		512
Current portion of lease liabilities			364			305		327
Payables and accrued charges	6		6,613			6,653		9,467
			10,957			11,312		12,121
Non-current liabilities
Long-term debt	8		9,383			9,427		8,913
Lease liabilities			1,029			901		999
Deferred income tax liabilities			3,555			3,631		3,574
Pension and other post-retirement benefit liabilities			245			241		252
Asset retirement obligations and accrued environmental costs			1,564			1,353		1,489
Other non-current liabilities			172			168		200
TOTAL LIABILITIES			26,905			27,033		27,548
SHAREHOLDERS' EQUITY
Share capital	9		13,827			13,837		13,838
Contributed surplus			67			82		83
Accumulated other comprehensive loss			(219)			(410)		(296)
Retained earnings			11,291			11,636		11,531
Equity holders of Nutrien			24,966			25,145		25,156
Non-controlling interest			40			51		45
TOTAL SHAREHOLDERS' EQUITY			25,006			25,196		25,201
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY			51,911			52,229		52,749
(See Notes to the Condensed Consolidated Financial Statements)

Notes to the Condensed Consolidated Financial Statements

As at and for the Three and Nine Months Ended September 30, 2024

Note 1 Basis of presentation

Nutrien Ltd. (collectively with its subsidiaries, "Nutrien", "we", "us", "our" or "the Company") is a leading global provider of crop inputs and services. Nutrien plays a critical role in helping growers around the globe increase food production.

These unaudited interim condensed consolidated financial statements ("interim financial statements") are based on International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, "Interim Financial Reporting". The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2023 annual audited consolidated financial statements, as well as any amended standards adopted in 2024 that we previously disclosed. These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2023 annual audited consolidated financial statements. Certain immaterial 2023 figures have been reclassified in the condensed consolidated statements of earnings, condensed consolidated statements of cash flows and Note 4 Other expenses (income).

In management's opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year. These interim financial statements were authorized for issue by the Audit Committee of the Board of Directors for issue on November 6, 2024.

Note 2 Segment information

We have four reportable operating segments: Nutrien Ag Solutions ("Retail"), Potash, Nitrogen and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seed and merchandise. Retail provides services directly to growers through a network of farm centers in North America, South America and Australia. The Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each produces. Potash freight, transportation and distribution costs only apply to our North American potash sales volumes. EBITDA presented in the succeeding tables is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

(millions of US dollars)	Retail		Potash		Nitrogen		Phosphate		Corporate and Others		Eliminations		Consolidated
Assets - as at September 30, 2024	22,585		13,686		11,303		2,412		2,443		(518)		51,911
Assets - as at December 31, 2023	23,056		13,571		11,466		2,438		2,818		(600)		52,749

		Three Months Ended September 30, 2024
(millions of US dollars)		Retail		Potash		Nitrogen		Phosphate		Corporate and Others		Eliminations		Consolidated
Sales	- third party	3,271		915		753		409		?		?		5,348
	- intersegment	?		113		163		58		?		(334)		?
Sales	- total	3,271		1,028		916		467		?		(334)		5,348
Freight, transportation and distribution		?		144		123		55		?		(59)		263
Net sales		3,271		884		793		412		?		(275)		5,085
Cost of goods sold		2,412		422		581		383		?		(213)		3,585
Gross margin		859		462		212		29		?		(62)		1,500
Selling expenses (recovery)		815		3		8		1		(2)		(5)		820
General and administrative expenses		51		5		6		4		90		?		156
Provincial mining taxes		?		74		?		?		?		?		74
Share-based compensation expense		?		?		?		?		1		?		1
Impairment of assets		?		?		?		?		?		?		?
Foreign exchange loss, net of related derivatives		?		?		?		?		31		?		31
Other expenses (income)		32		2		(25)		10		194		9		222
Earnings (loss) before finance costs and income taxes		(39)		378		223		14		(314)		(66)		196
Depreciation and amortization		190		177		132		75		24		?		598
EBITDA		151		555		355		89		(290)		(66)		794
Share-based compensation expense		?		?		?		?		1		?		1
ARO/ERL related expense for non-operating sites		?		?		?		?		184		?		184
Foreign exchange loss, net of related derivatives		?		?		?		?		31		?		31
Adjusted EBITDA		151		555		355		89		(74)		(66)		1,010

		Three Months Ended September 30, 2023
(millions of US dollars)		Retail		Potash		Nitrogen		Phosphate		Corporate and Others		Eliminations		Consolidated
Sales	- third party	3,489		1,002		690		450		?		?		5,631
	- intersegment	1		108		138		66		?		(313)		?
Sales	- total	3,490		1,110		828		516		?		(313)		5,631
Freight, transportation and distribution		?		138		105		72		?		(52)		263
Net sales		3,490		972		723		444		?		(261)		5,368
Cost of goods sold		2,595		389		569		417		?		(229)		3,741
Gross margin		895		583		154		27		?		(32)		1,627
Selling expenses (recovery)		798		3		8		1		(3)		(8)		799
General and administrative expenses		57		2		1		3		88		?		151
Provincial mining taxes		?		96		?		?		?		?		96
Share-based compensation expense		?		?		?		?		42		?		42
Foreign exchange loss, net of related derivatives		?		?		?		?		87		?		87
Other expenses (income)		37		4		(19)		8		30		7		67
Earnings (loss) before finance costs and income taxes		3		478		164		15		(244)		(31)		385
Depreciation and amortization		189		133		130		75		25		?		552
EBITDA		192		611		294		90		(219)		(31)		937
Integration and restructuring related costs		5		?		?		?		9		?		14
Share-based compensation expense		?		?		?		?		42		?		42
ARO/ERL related expense for non-operating sites		?		?		?		?		4		?		4
Foreign exchange loss, net of related derivatives		?		?		?		?		87		?		87
Adjusted EBITDA		197		611		294		90		(77)		(31)		1,084

		Nine Months Ended September 30, 2024
(millions of US dollars)		Retail		Potash		Nitrogen		Phosphate		Corporate and Others		Eliminations		Consolidated
Sales	- third party	14,653		2,486		2,547		1,207		?		?		20,893
	- intersegment	?		305		584		210		?		(1,099)		?
Sales	- total	14,653		2,791		3,131		1,417		?		(1,099)		20,893
Freight, transportation and distribution		?		338		399		174		?		(170)		741
Net sales		14,653		2,453		2,732		1,243		?		(929)		20,152
Cost of goods sold		11,018		1,139		1,835		1,116		?		(905)		14,203
Gross margin		3,635		1,314		897		127		?		(24)		5,949
Selling expenses (recovery)		2,610		9		23		5		(7)		(18)		2,622
General and administrative expenses		154		10		16		11		277		?		468
Provincial mining taxes		?		210		?		?		?		?		210
Share-based compensation expense		?		?		?		?		17		?		17
Impairment of assets		335		?		195		?		?		?		530
Foreign exchange loss, net of related derivatives		?		?		?		?		359		?		359
Other expenses (income)		95		3		(136)		26		274		22		284
Earnings (loss) before finance costs and income taxes		441		1,082		799		85		(920)		(28)		1,459
Depreciation and amortization		580		475		419		213		62		?		1,749
EBITDA		1,021		1,557		1,218		298		(858)		(28)		3,208
Share-based compensation expense		?		?		?		?		17		?		17
Impairment of assets		335		?		195		?		?		?		530
Loss related to financial instruments in Argentina		?		?		?		?		34		?		34
ARO/ERL related expense for non-operating sites		?		?		?		?		152		?		152
Foreign exchange loss, net of related derivatives		?		?		?		?		359		?		359
Adjusted EBITDA		1,356		1,557		1,413		298		(296)		(28)		4,300

		Nine Months Ended September 30, 2023
(millions of US dollars)		Retail		Potash		Nitrogen		Phosphate		Corporate and Others		Eliminations		Consolidated
Sales	- third party	16,038		3,001		2,909		1,444		?		?		23,392
	- intersegment	2		302		708		204		?		(1,216)		?
Sales	- total	16,040		3,303		3,617		1,648		?		(1,216)		23,392
Freight, transportation and distribution		?		320		366		188		?		(160)		714
Net sales		16,040		2,983		3,251		1,460		?		(1,056)		22,678
Cost of goods sold		12,599		1,047		2,157		1,297		?		(1,128)		15,972
Gross margin		3,441		1,936		1,094		163		?		72		6,706
Selling expenses		2,534		9		23		5		(7)		(16)		2,548
General and administrative expenses		162		10		11		10		260		?		453
Provincial mining taxes		?		319		?		?		?		?		319
Share-based compensation recovery		?		?		?		?		(7)		?		(7)
Impairment of assets		465		?		?		233		?		?		698
Foreign exchange loss, net of related derivatives		?		?		?		?		105		?		105
Other expenses (income)		81		2		(53)		21		82		5		138
Earnings (loss) before finance costs and income taxes		199		1,596		1,113		(106)		(433)		83		2,452
Depreciation and amortization		558		345		426		213		62		?		1,604
EBITDA		757		1,941		1,539		107		(371)		83		4,056
Integration and restructuring related costs		8		?		?		?		21		?		29
Share-based compensation recovery		?		?		?		?		(7)		?		(7)
Impairment of assets		465		?		?		233		?		?		698
Loss related to financial instruments in Argentina		?		?		?		?		92		?		92
ARO/ERL related expense for non-operating sites		?		?		?		?		10		?		10
Foreign exchange loss, net of related derivatives		?		?		?		?		105		?		105
Adjusted EBITDA		1,230		1,941		1,539		340		(150)		83		4,983

	Three Months Ended					Nine Months Ended
	September 30					September 30
(millions of US dollars)	2024			2023		2024			2023
Retail sales by product line
Crop nutrients	1,093			1,250		5,683			6,571
Crop protection products	1,518			1,566		5,365			5,790
Seed	132			158		2,051			2,093
Services and other	242			235		690			691
Merchandise	222			231		667			750
Nutrien Financial	85			73		284			252
Nutrien Financial elimination 1	(21)			(23)		(87)			(107)
	3,271			3,490		14,653			16,040
Potash sales by geography
Manufactured product
North America	601			637		1,474			1,631
Offshore 2	427			473		1,316			1,672
Other potash and purchased products	?			?		1			?
	1,028			1,110		2,791			3,303
Nitrogen sales by product line
Manufactured product
Ammonia	261			193		856			998
Urea and ESN®	293			297		1,085			1,278
Solutions, nitrates and sulfates	299			270		961			1,022
Other nitrogen and purchased products	63			68		229			319
	916			828		3,131			3,617
Phosphate sales by product line
Manufactured product
Fertilizer	316			295		928			886
Industrial and feed	148			151		470			535
Other phosphate and purchased products	3			70		19			227
	467			516		1,417			1,648
1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.
2 Relates to Canpotex Limited ("Canpotex") (Note 11) and includes provisional pricing adjustments for the three months ended September 30, 2024 of $(4) million (2023 - $(34) million) and the nine months ended September 30, 2024 of $7 million (2023 - $(354) million).

Note 3 Impairment of assets

We recorded the following non-cash impairment of assets in the condensed consolidated statements of earnings:

				Nine Months Ended
				September 30
(millions of US dollars)				2024			2023
Segment	Category
Retail	Intangible assets			200			43
	Property, plant and equipment			120			?
	Other			15			?
	Goodwill			?			422
Nitrogen	Property, plant and equipment			195			?
Phosphate	Property, plant and equipment			?			233
Impairment of assets				530			698

Retail - Brazil

At June 30, 2024, due to the ongoing market instability and more moderate margin expectations, we lowered our forecasted EBITDA for the Retail - Brazil cash generating unit ("CGU"). This triggered an impairment analysis. Prior to June 30, 2023, the Retail - Brazil CGU was part of the Retail - South America group of CGUs at which time the goodwill of the group was deemed to be fully impaired.

We used the fair value less cost to dispose ("FVLCD") methodology (level 3) based on a market approach to assess the recoverable value of the Retail - Brazil CGU at June 30, 2024. This is a change from our 2023 analysis, as the market approach resulted in a more representative fair value of the CGU as restructuring initiatives in Brazil are currently being developed. In 2023, we used the FVLCD methodology based on after-tax discounted cash flows (10-year projections plus a terminal value) and an after-tax discount rate (14.4 percent). We incorporated assumptions that an independent market participant would apply.

The key assumptions with the greatest influence on the calculation of the impairment are the estimated recoverable value of property, plant and equipment and intangible assets. Any change to these estimates could directly impact the impairment amount.

		Retail - Brazil
(millions of US dollars)		June 30, 2024
Recoverable amount comprised of:
Working capital and other		324
Property, plant and equipment		92
Intangible assets		?

Nitrogen

During the three months ended June 30, 2024, we decided that we are no longer pursuing our Geismar Clean Ammonia project. As a result, we recorded an impairment loss of $195 million to fully write-off the amount of property, plant and equipment related to this project. As the project was cancelled before it generated revenue, the recoverable amount, which was based on its value in use, is $nil.

At June 30, 2023, we recorded an impairment of $465 million on our Retail - South America groups of CGUs and $233 million on our Phosphate - White Springs CGU. Refer to Note 13 of our 2023 annual audited consolidated financial statements for further details.

Note 4 Other expenses (income)

	Three Months Ended					Nine Months Ended
	September 30					September 30
(millions of US dollars)	2024			2023		2024			2023
Integration and restructuring related costs	?			14		?			29
Earnings of equity-accounted investees	(26)			(28)		(107)			(100)
Bad debt expense	31			12		94			51
Project feasibility costs	19			19		62			53
Customer prepayment costs	10			10		41			36
Insurance recoveries	(3)			?		(70)			?
Loss on natural gas derivatives not designated as hedge 1	5			?		7			?
Loss related to financial instruments in Argentina	?			?		34			92
ARO/ERL related expenses for non-operating sites 2	184			4		152			10
Gain on amendments to other post-retirement pension plans	?			?		?			(80)
Other expenses	2			36		71			47
	222			67		284			138
1 Includes realized loss of $3 million and $5 million for the three and nine months ended September 30, 2024 (2023 - $nil) and unrealized loss of $2 million for the three and nine months ended September 30, 2024, respectively (2023 - $nil).
2 ARO/ERL refers to asset retirement obligations and accrued environmental costs.

Argentina has certain currency controls in place that limit our ability to settle our foreign currency-denominated obligations or remit cash out of Argentina. We utilize various financial instruments such as Blue Chip Swaps or Bonds for the Reconstruction of a Free Argentina ("BOPREAL") that effectively allow companies to transact in US dollars. We incurred losses on these transactions due to the significant divergence between the market exchange rate used for these financial instruments and the official Central Bank of Argentina rate. These losses are recorded as part of loss related to financial instruments in Argentina.

Note 5 Income taxes

A separate estimated average annual effective income tax rate was determined and applied individually to the interim period pre-tax earnings for each taxing jurisdiction.

	Three Months Ended					Nine Months Ended
	September 30					September 30
(millions of US dollars, except as otherwise noted)	2024			2023		2024			2023
Actual effective tax rate on earnings (%)	(18)			41		41			33
Actual effective tax rate including discrete items (%)	(112)			54		38			41
Discrete tax adjustments that impacted the tax rate	(11)			23		(31)			155

Note 6 Financial instruments

Foreign Currency Derivatives

	Three Months Ended					Nine Months Ended
	September 30					September 30
(millions of US dollars)	2024			2023		2024			2023
Foreign exchange (gain) loss	(3)			32		27			12
Hyperinflationary loss	20			46		85			78
Loss on foreign currency derivatives at fair value through profit or loss	14			9		247			15
Foreign exchange loss, net of related derivatives	31			87		359			105

During the nine months ended September 30, 2024, we entered into various foreign currency derivative contracts. The losses on our foreign currency derivatives were primarily related to Brazil which matured in July 2024. As of September 30, 2024, outstanding derivative contracts were related to our ongoing risk management strategy. The fair value of our net foreign exchange currency derivative assets (liabilities) as at September 30, 2024 was $3 million (December 31, 2023 - $11 million).

	As at September 30, 2024						As at December 31, 2023
(millions of US dollars, except as otherwise noted)	Notional		Maturities (year)		Average Contract Rate (1:1)		Notional		Maturities (year)		Average Contract Rate (1:1)
Derivatives not designated as hedges
Forwards (Sell/buy)
USD/Canadian dollars ("CAD")	416		2024		1.3445		435		2024		1.3207
Brazilian real ("BRL")/USD	213		2024		5.4668		94		2024		4.8688
Australian dollars ("AUD")/USD	75		2025		1.4940		86		2024		1.5269
USD/BRL	94		2025		5.5408		?		?		?
USD/BRL	58		2025		5.6617		?		?		?
USD/AUD	11		2024		1.4904		?		?		?
Derivatives designated as hedges
Forwards (Sell/buy)
USD/CAD	485		2025		1.3638		601		2024		1.3565

Natural Gas Derivatives

In 2024, we increased our use of natural gas derivatives to lock-in commodity prices. Our risk management strategies and accounting policies for derivatives that are designated and qualify as cash flow hedges are consistent with those disclosed in Note 10 and Note 30 of our annual consolidated financial statements, respectively. For derivatives that do not qualify as cash flow hedges, any gains or losses are recorded in net earnings in the current period.

We assess whether our derivative hedging transactions are expected to be or were highly effective, both at the hedge's inception and on an ongoing basis, in offsetting changes in fair values of hedged items.

Hedging Transaction		Measurement of Ineffectiveness		Potential Sources of Ineffectiveness
New York Mercantile Exchange ("NYMEX") natural gas hedges		Assessed on a prospective and retrospective basis using regression analyses		Changes in: • timing of forecast transactions • volume delivered • our credit risk or the credit risk of a counterparty

The table below presents information about our natural gas derivatives which are used to manage the risk related to significant price changes in natural gas.

	As at September 30, 2024
(millions of US dollars, except as otherwise noted)	Notional 1		Maturities (year)		Average Contract Price 2		Fair Value of Assets (Liabilities) 3
Derivatives not designated as hedges
NYMEX call options	15		2024		3.15		1
Derivatives designated as hedges
NYMEX swaps	12		2024		3.06		(1)
1 In millions of Metric Million British Thermal Units ("MMBtu").
2 US dollars per MMBtu.
3 Fair value of natural gas derivatives are based on a discounted cash flow model which are classified as Level 2.

Our financial instruments carrying amount are a reasonable approximation of their fair values, except for our long-term debt that has a carrying value of $10,396 million and fair value of $10,194 million as at September 30, 2024. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.

Note 7 Short-term debt

On March 7, 2024, we entered into an uncommitted $500 million accounts receivable repurchase facility (the "repurchase facility"), where we may sell certain receivables from customers to a financial institution and agree to repurchase those receivables at a future date. When we draw under this repurchase facility, the receivables from customers remain on our condensed consolidated balance sheet as we control and retain substantially all of the risks and rewards associated with the receivables. As at September 30, 2024, there were no borrowings outstanding under this facility.

During the three months ended September 30, 2024, we extended the term of our unsecured revolving term credit facility to September 3, 2025 and reduced the facility limit from $1,500 million to $750 million. We also extended the maturity of our $4,500 million unsecured revolving term facility to September 4, 2029.

Note 8 Long-term debt

Issuances in the nine months ended September 30, 2024
(millions of US dollars, except as otherwise noted)	Rate of interest (%)		Maturity		Amount
Senior notes issued 2024	5.2		June 21, 2027		400
Senior notes issued 2024	5.4		June 21, 2034		600
					1,000

The notes issued in the nine months ended September 30, 2024, are unsecured, rank equally with our existing unsecured debt, and have no sinking fund requirements prior to maturity. Each series is redeemable and has various provisions for redemption prior to maturity, at our option, at specified prices.

In March 2024, we filed a base shelf prospectus in Canada and the US qualifying the issuance of common shares, debt securities and other securities during a period of 25 months from March 22, 2024.

Note 9 Share capital

Share Repurchase Programs

The following table summarizes our share repurchase activities during the periods indicated below:

	Three Months Ended					Nine Months Ended
	September 30					September 30
(millions of US dollars, except as otherwise noted)	2024			2023		2024			2023
Number of common shares repurchased for cancellation	1,039,185			?		1,039,185			13,378,189
Average price per share (US dollars)	48.11			?		48.11			74.73
Total cost, inclusive of tax	51			?		51			1,000

As of November 5, 2024, an additional 477,671 common shares were repurchased for cancellation at a cost of $23 million and an average price per share of $48.68.

Note 10 Seasonality

Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. The results of this seasonality have a corresponding effect on receivables from customers and rebates receivables, inventories, prepaid expenses and other current assets, and trade payables. Our short-term debt also fluctuates during the year to meet working capital requirements. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are typically concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

Note 11 Related party transactions

We sell potash outside Canada and the US exclusively through Canpotex. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed upon prices. Our total revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex.

As at (millions of US dollars)	September 30, 2024			December 31, 2023
Receivables from Canpotex	195			162

Note 12 Accounting policies, estimates and judgments

IFRS 18, "Presentation and Disclosure in Financial Statements" ("IFRS 18"), which was issued on April 9, 2024, would supersede IAS 1, "Presentation of Financial Statements" and increase the comparability of financial statements by enhancing principles on aggregation and disaggregation. IFRS 18 will be effective January 1, 2027, and will also apply to comparative information. We are reviewing the standard to determine the potential impact.

Amendments for IFRS 9 and IFRS 7, "Amendments to the Classification and Measurement of Financial Instruments", which was issued on May 30, 2024, will address diversity in practice by making the requirements more understandable and consistently applied. These amendments will be effective January 1, 2026, and will not apply to comparative information. We are reviewing the standard to determine the potential impact.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241101408237/en/

Contact

Jeff Holzman
Vice President, Investor Relations
(306) 933-8545
Investors@nutrien.com